{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:14:21Z","timestamp":1771017261521,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jbspin.2009.10.012","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T03:44:41Z","timestamp":1264563881000},"page":"135-141","source":"Crossref","is-referenced-by-count":15,"title":["Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment"],"prefix":"10.1016","volume":"77","author":[{"given":"Marie-Ga\u00eblle","family":"Bray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.10.012_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2009.10.012_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.012_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.jbspin.2009.10.012_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/ard.61.suppl_2.ii62","article-title":"Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents","volume":"61","author":"Furst","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib6","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.012_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care C.","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.jbspin.2009.10.012_bib8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.012_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0761-8425(08)75089-7","article-title":"Tuberculosis anti-TNF agents and other immunosuppressants: evolution of preventive strategies","volume":"25","author":"Liote","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.jbspin.2009.10.012_bib10","unstructured":"Afssaps. Recommandations nationales\u00a0: pr\u00e9vention et prise en charge des tuberculoses survenant sous anti-TNF\u03b1. 2002."},{"key":"10.1016\/j.jbspin.2009.10.012_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0761-8425(05)85435-X","article-title":"Tuberculosis control in France: evaluation of practice by a working group of the Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","volume":"22","author":"Fraisse","year":"2005","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.jbspin.2009.10.012_bib12","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2009.10.012_bib13","first-page":"414","article-title":"Guidelines for the management of tuberculosis in France","volume":"21","author":"Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","year":"2004","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.jbspin.2009.10.012_bib14","first-page":"300","article-title":"Short-course isoniazid and rifampin compared with isoniazid for latent tuberculosis infection: a randomized clinical trial","volume":"25","author":"Geijo","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jbspin.2009.10.012_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.012_bib16","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.jbspin.2009.10.012_bib17","unstructured":"WHO. International monitoring of adverse reactions to drugs: adverse reaction terminology. WHO collaborating center for international drug monitoring. 1992."},{"key":"10.1016\/j.jbspin.2009.10.012_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0248-8663(97)83418-2","article-title":"Tuberculosis and systemic diseases. A propos of 16 cases","volume":"19","author":"Darras-Joly","year":"1998","journal-title":"Rev Med Int"},{"key":"10.1016\/j.jbspin.2009.10.012_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard.2006.064543","article-title":"The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice","volume":"66","author":"Van der Cruyssen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib20","first-page":"197","article-title":"Rheumatoid arthritis therapeutic management in France in 2006: the OPALE study","volume":"67","author":"Combe","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"G\u00f3mez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.10.012_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3346\/jkms.2007.22.5.779","article-title":"Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea","volume":"22","author":"Yun","year":"2007","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jbspin.2009.10.012_bib23","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","article-title":"Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country","volume":"293","author":"Kang","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2009.10.012_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"Lee","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2009.10.012_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.08-2048","article-title":"Comparative performance of tuberculin skin test. Quantiferon-TB-Gold in Tube assay and T-Spot-TB test in contact investigations for tuberculosis","volume":"135","author":"Diel","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2009.10.012_bib26","first-page":"31","article-title":"Latent tuberculosis: which test in which situation?","volume":"138","author":"Zellweger","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbspin.2009.10.012_bib27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-007-0591-4","article-title":"Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha","volume":"26","author":"Hanta","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.012_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2007.076406","article-title":"Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic","volume":"67","author":"Mor","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jbspin.2009.10.012_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: recommendations","volume":"53","author":"Joint Tuberculosis Cot","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jbspin.2009.10.012_bib31","first-page":"168","article-title":"Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDs","volume":"24","author":"Bettembourg-Brault","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2009.10.012_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.10.012_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"Fountain","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2009.10.012_bib34","first-page":"256","article-title":"Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity","volume":"4","author":"Ohno","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jbspin.2009.10.012_bib35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1440-1746.2001.02585.x","article-title":"Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 null mutation","volume":"16","author":"Roy","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2009.10.012_bib36","first-page":"491","article-title":"The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs","volume":"4","author":"Perez Gutthann","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.jbspin.2009.10.012_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archinte.154.3.311","article-title":"Acute liver injury associated with non steroidal anti-inflammatory drugs and the role of risk factors","volume":"154","author":"Garcia Rodriguez","year":"1994","journal-title":"Arch Intern Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09002486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T13:53:54Z","timestamp":1544709234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09002486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1297319X09002486"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.10.012","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}